ArticleJournal of racial and ethnic health disparities2026
Ethnic Disparities in Glycemic Control among Malaysian Adults with Type 2 Diabetes: A Retrospective Multivariable Analysis.
Article in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAchieving optimal glycemic control in patients with type 2 diabetes remains a global clinical challenge, particularly in ethnically diverse regions such as Malaysia.
objectiveTo evaluate the associations between sociodemographic factors, BMI treatment types, comorbidities and diabetes duration with glycemic control among Malaysia's three major ethnic groups of adults with type 2 diabetes.
methodsA retrospective review of 642 patient records with equal ethnic representation (n = 214 each) was conducted at Hospital Sultan Abdul Aziz Shah, from June 2024 to May 2025. Patient data, including age, gender, ethnicity, BMI, comorbidities, diabetes duration, and pharmacological treatment, were collected. Haemoglobin A1c (HbA1c) levels over time were analysed using linear mixed models, adjusting for demographic and clinical covariates.
resultsThe median age of the patients was 65 years, with males predominating: Malays (n = 115, 53.7%), Chinese (n = 128, 59.8%), and Indians (n = 128, 59.8%). Approximately 2.3% (n = 15) were underweight, 36.3% (n = 233) had normal weight, 35.2% (n = 226) were overweight, and 26.2% (n = 168) were obese. About 53.6% received combination therapy. Hypertension only was present in 6.6% (n = 42), dyslipidemia only in 15.4% (n = 99), both conditions in 75.2% (n = 483), and 2.8% (n = 18) had no comorbidities. About 19.4% (n = 124) had a diabetes duration of < 5 years, 35.5% (n = 228) had 6 to 10 years, 24.1% (n = 155) had 11 to 15 years, and 21.0% (n = 135) had ≥ 16 years. Age, gender, ethnicity, and treatment were significantly associated with HbA1c levels (p < 0.05). However, only age, gender and treatment showed a significant association with HbA1c changes over time (p < 0.05). Notably, older age, females, Chinese ethnicity, and being on monotherapy were associated with better glycemic outcomes.
conclusionAge, gender, ethnicity, and treatment are key determinants of glycemic control in Malaysian adults with type 2 diabetes. Personalised treatment strategies, focusing on younger patients, males, those of Malay or Indian ethnicity, and the selective use of monotherapy, may improve glycemic outcomes and reduce complications.
Indexed as
Identifiers
41543785What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.